Skip to main content
Home
  • The Network
    • Membership
    • Who we are
    • Make the most of our services
    • Cambridge Cluster
    • Cambridge NeuroWorks
    • FAQ
  • Companies
    • Member directory
  • News
    • News listing
    • Blog
  • Events
    • All events
    • Cambridge Network events
    • Advertise your event
    • Boost your event
    • Sponsorship
  • Learning
    • Training courses
    • In-house courses
    • Coaching services
    • Graduate scheme
    • Consultancy services
    • Peer groups
    • Learning FAQ
  • Jobs
    • Jobs listing
    • Recruitment Packages
    • Advertise your vacancies
    • Connect with future talent
    • Boost your job
    • Tips for finding a job
More
    • Contact us
    • Join the network
    • My profile
    • Log in
    • The Network
      • Membership
      • Who we are
      • Make the most of our services
      • Cambridge Cluster
      • Cambridge NeuroWorks
      • FAQ
    • Companies
      • Member directory
    • News
      • News listing
      • Blog
    • Events
      • All events
      • Cambridge Network events
      • Advertise your event
      • Boost your event
      • Sponsorship
    • Learning
      • Training courses
      • In-house courses
      • Coaching services
      • Graduate scheme
      • Consultancy services
      • Peer groups
      • Learning FAQ
    • Jobs
      • Jobs listing
      • Recruitment Packages
      • Advertise your vacancies
      • Connect with future talent
      • Boost your job
      • Tips for finding a job

    Breadcrumb

    1. Home
    2. Healthcare and Life Science

    Healthcare and Life Science

    5 February 2021

    The Global Blood Pressure Problem: is the Solution Staring Us In The Face?

    LET'S START WITH THE FACTS

    31 July 2023

    Global Access Diagnostics (GADx) reintroduces IT-Leish, the rapid diagnostic test for visceral leishmaniasis

    London, UK - Global Access Diagnostics (GADx), a social enterprise prioritising equitable access to diagnostics, announces the launch of IT-Leish, a rapid diagnostic test (RDT) for visceral leishmaniasis (VL). ...

    28 July 2023

    electronRx moves to new premises to facilitate growth plans

    Cambridge-based health tech company electronRx has moved into its new office within Compass House in Histon to facilitate its future expansion. ...

    28 July 2023

    Class of 2023 SBC Catalyser Programme ‘graduate’ with flying colours

    Ten startups at the intersection of therapeutics and techbio have celebrated completing Stevenage Bioscience Catalyst’s Catalyser Programme by pitching their ideas and commercialisation strategies to an audience of investors, experts and invited guests. ...

    28 July 2023

    Occupational health consultation seeks to increase support for employers

    The Government is seeking views on proposals aimed at increasing use of Occupational Health Services by UK employers. ...

    27 July 2023

    Gyros Protein Technologies introduces PurePep EasyClean Auto Kit for automated parallel peptide purification

    New automated kit overcomes major bottleneck in peptide production, providing optimized simultaneous workflows ...

    20 July 2023

    Celebrating our Centres - Maudsley

    This week we hear from the team at NIHR BioResource Centre London Maudsley about what they’ve been up to post-pandemic. Volunteer recruitment, research studies, and community events are just a few to name alongside an exciting new initiative being launched in collaboration with the NIHR...

    26 July 2023

    DLOC partners with 42 Technology to develop ‘human-on-chip’ system

    DLOC Biosystems (DLOC), a spin-out from the American University of Beirut, has appointed 42 Technology (42T) as a strategic product development partner to help bring its advanced 3D human-on-chip technology and fully-automated operating system to market. ...

    25 July 2023

    Elucidare receives award to develop spatial audio applications for mental health therapies

    Elucidare, the commercialization and investment due diligence consultancy, announces the receipt of an award from Innovate UK for the development of spatial audio as a mental health therapy. ...

    25 July 2023

    NK:IO raises £1.2M, bringing total Seed funding to £5.1M, to advance pioneering NK cell therapy

    NK:IO, a leader in natural killer (NK) cell biology applied to the development of exceptionally potent, off-the-shelf cell therapies targeting solid tumours, has raised £1.2M. This brings total equity financing to £3.2M and will enable the company to reach key milestones in progressing ...

    Pagination

    • First page «
    • Previous page ‹‹
    • …
    • Page 176
    • Page 177
    • Current page 178
    • Page 179
    • Page 180
    • …
    • Next page ››
    • Last page »
    Receive our newsletter

    Footer menu

    • Terms & Conditions
    • Disclaimer
    • Privacy
    • Cookies
    • FAQ

    Cambridge Network Limited is a company registered in England under company No. 3400152

    The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

    Email: [email protected], Tel: 01223 746801

    © 2026 Cambridge Network. All Rights Reserved.

    Website by KISS